Patient preferences for Eucreas® versus Victoza® in Type 2 Diabetes mellitus patients

Update Il y a 4 ans
Reference: EUCTR2011-003818-16

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of this trial is to demonstrate that a higher proportion of subjects with T2DM and inadequate glycemic control have a preference for an oral treatment with the SPC of vildagliptin/metformin compared to an injectable treatment with liraglutide as add-on to metformin after experiencing both treatments.


Inclusion criteria

  • Type 2 diabetes mellitus

Links